// App-Quantinova.ai

2603 : Southwest Oncology Group Study S0910: A Phase 2 Trial of Clofarabine/ Cytarabine/ Epratuzumab for Relapsed/ Refractory Acute Lymphocytic Leukemia.

Researchers

Presenter

  • Shannon McDonough

Principal Investigators

  • Steven Coutre

  • Brent L. Wood

  • Jerald P. Radich

  • Martha Mims

  • Margaret -Donnell

  • Stephanie Elkins

  • Michael W. Becker

  • Megan Othus

  • Frederick R. Appelbaum

Medical Centers

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • SWOG Statistical Center, Seattle, WA

  • University of Mississippi, Jackson, MS

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute renal failure

  • Cardiac arrest

  • Hypercalcaemia

  • Neutropenia

  • Sepsis

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • B-lymphocyte antigen CD20

  • Cluster of Differentiation 19

  • Cluster of Differentiation 34

  • Cluster of Differentiation 38

  • Cluster of differentiation 45

  • White Blood Cell

Drug/Treatment

  • Clofarabine

  • Epratuzumab

  • Cytarabine liposomal

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved